logo
  

Delta Air Lines Sees Q3 Adj. Revenue At Lower End Of Prior Guidance - Quick Facts

Delta Air Lines, Inc. (DAL) said its third-quarter total adjusted revenue, excluding third-party refinery sales, is now projected to be at the lower end of the prior guidance range as the recent rise in COVID cases is suppressing demand. Non-fuel unit cost is now expected to increase approximately 15 percent from 2019, which is 2.5 points above the midpoint of prior guidance. The company expects to report an adjusted pretax profit in the third quarter.

Delta Air Lines is moderating capacity for the December quarter by 3 to 5 points versus 2019 relative to prior plans.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Privately-held biotechnology company On Target Laboratories, Inc. announce that the U.S. Food and Drug Administration or FDA, has approved Cytalux (pafolacianine) for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions. Cytalux is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively. The Federal Trade Commission or FTC has ordered Walmart, Amazon, Kroger and certain other large wholesalers and suppliers to provide information to help it study causes of supply chain disruptions. The agency has launched an inquiry to find the reasons for empty shelves and exorbitant prices. Along with Walmart, Amazon.com, and Kroger, the order has been sent to C&S Wholesale Grocers, Associated.. Covid vaccine maker Moderna Inc.'s Chief Executive Stéphane Bancel has predicted that existing COVID-19 vaccines will be much less effective against Omicron than earlier strains, according to the Financial Times.
Follow RTT